Journal of Microbiology and Biotechnology

The Korean Society for Microbiology and Biotechnology (한국미생물·생명공학회)
권호 표지
DOI QR코드

DOI QR Code

Lactic Acid Bacteria Isolated from Human Breast Milk Improve Colitis Induced by 2,4,6-Trinitrobenzene Sulfonic Acid by Inhibiting NF-κB Signaling in Mice

  • Kyung-Joo Kim (Department of Food and Nutrition, Eulji University) ;
  • Suhyun Kyung (Department of Research, GREEN CROSS Wellbeing Co., Ltd.) ;
  • Hui Jin (Department of Research, GREEN CROSS Wellbeing Co., Ltd.) ;
  • Minju Im (Department of Research, GREEN CROSS Wellbeing Co., Ltd.) ;
  • Jae-won Kim (Department of Research, GREEN CROSS Wellbeing Co., Ltd.) ;
  • Hyun Su Kim (BTC Corporation #906, Technology Development Centre) ;
  • Se-Eun Jang (Department of Food and Nutrition, Eulji University)
  • Received : 2023.03.15
  • Accepted : 2023.04.25
  • Published : 2023.08.28
Download PDF
⟨ Previous Next ⟩

Abstract

Inflammatory bowel disease (IBD), a chronic inflammatory disease, results from dysregulation of the immune responses. Some lactic acid bacteria (LAB), including Lactobacillus, alleviate IBD through immunomodulation. In this study, the anti-colitis effect of LAB isolated from human breast milk was investigated in a mouse model induced acute colitis with 2,4,6-trinitrobenzene sulfonic acid (TNBS). TNBS remarkably increased weight loss, colon shortening, and colonic mucosal proliferation, as well as the expression levels of inflammatory cytokines, including tumor necrosis factor-alpha (TNF-α) and interleukin (IL)-1β. Oral administration of LAB isolated from human breast milk resulted in a reduction in TNBS-induced colon shortening, as well as induced cyclooxygenase (COX)-2, nitric oxide synthase (iNOS), nuclear factor-kappa B (NF-κB). In addition, LAB suppressed inflammatory cytokines such as TNF-α, IL-6, and IL-1β, and thus showed an effect of suppressing the level of inflammation induced by TNBS. Furthermore, LAB alleviated gut microbiota dysbiosis, and inhibited intestinal permeability by increasing the expression of intestinal tight junction protein including ZO-1. Collectively, these results suggest that LAB isolated from human breast milk can be used as a functional food for colitis treatment by regulating NF-κB signaling, gut microbiota and increasing expression of intestinal tight junction protein.

Keywords

Acknowledgement

This study was supported by GC Well-being.

References

  1. Jeong JH, Kim K, Lim D, Kim KH, Kim HS, Lee S, et al. 2017. Microvasculature remodeling in the mouse lower gut during inflammaging. Sci. Rep. 7: 39848.
  2. Jeong JJ, Kim KA, Jang SE, Woo JY, Han MJ, Kim DH. 2015. Orally administrated Lactobacillus pentosus var. plantarum C29 ameliorates age-dependent colitis by inhibiting the nuclear factor-kappa B signaling pathway via the regulation of lipopolysaccharide production by gut microbiota. PLoS One 10: e0116533.
  3. Park SH, Kim YJ, Rhee KH, Kim YH, Hong SN, Kim KH, et al. 2019. Songpa-Kangdong Inflammatory Bowel Disease [SK-IBD] Study Group. A 30-year trend analysis in the epidemiology of inflammatory bowel disease in the Songpa-Kangdong district of Seoul, Korea in 1986-2015. 2019. J. Crohns. Colitis 13: 1410-1417. https://doi.org/10.1093/ecco-jcc/jjz081
  4. Lonnfors S, Vermeire S, Greco M, Hommes D, Bell C, Avedano L. 2014. IBD and health-related quality of life: discovering the true impact. J. Crohns Colitis 8: 1281-1286. https://doi.org/10.1016/j.crohns.2014.03.005
  5. Moon JS. 2019. Clinical aspects and treatments for pediatric inflammatory bowel disease. Intest. Res. 17: 17-23. https://doi.org/10.5217/ir.2018.00139
  6. Kim JW, Lee CK, Rhee SY, Oh CH, Shim JJ, Kim HJ. 2018. Trends in health-care costs and utilization for inflammatory bowel disease from 2010 to 2014 in Korea: a nationwide population-based study. J. Gastroenterol. Hepatol. 33: 847-854. https://doi.org/10.1111/jgh.14027
  7. Neuman MG, Nanau RM. Inflammatory bowel disease: role of diet, microbiota, life style. 2012. Trans. Res. 160: 29-44. https://doi.org/10.1016/j.trsl.2011.09.001
  8. Shanahan F. Gut flora in gastrointestinal disease. 2002. Eur. J. Surg. Suppl. 587: 47-52.
  9. Ahuja V, Tandon RK. 2010. Inflammatory bowel disease in the Asia-Pacific area: a comparison with developed countries and regional differences. J. Dig. Dis. 11: 134-147. https://doi.org/10.1111/j.1751-2980.2010.00429.x
  10. Marteau P, Cellier C. 1997. Side effects of 5-aminosalicylic acid. Gastroenterol. Clin. Biol. 21: 377-386.
  11. Collins MP, Gibson GR. 1999. Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial ecology of the gut. Am. J. Clin. Nutr. 69: s1052-1057. https://doi.org/10.1093/ajcn/69.5.1052s
  12. Paveljsek D, Juvan P, Kosir R, Rozman D, Hacin B, Ivicak-Kocjan K, et al. 2018. Lactobacillus fermentum L930BB and Bifidobacterium animalis subsp. animalis IM386 initiate signalling pathways involved in intestinal epithelial barrier protection. Benef. Microbes 9: 515-525. https://doi.org/10.3920/BM2017.0107
  13. Peran L, Camuesco D, Comalada M, Bailon E, Henriksson A, Xaus J, et al. 2007. A comparative study of the preventative effects exerted by three probiotics, Bifidobacterium lactis, Lactobacillus casei and Lactobacillus acidophilus, in the TNBS model of rat colitis. J. Appl. Microbiol. 103: 836-844. https://doi.org/10.1111/j.1365-2672.2007.03302.x
  14. Jang SE, Min SW. 2020. Lactobacillus sakei S1 improves colitis induced by 2,4,6-trinitrobenzene sulfonic acid by the inhibition of NF-κB signaling in mice. J. Microbiol. Biotechnol. 30: 71-78. https://doi.org/10.4014/jmb.1907.07050
  15. Jang SE, Han MJ, Kim SY, Kim DH. 2014. Lactobacillus plantarum CLP-0611 ameliorates colitis in mice by polarizing M1 to M2-like macrophages. Int. Immunopharmacol. 21: 186-192. https://doi.org/10.1016/j.intimp.2014.04.021
  16. Jang SE, Min SW. 2020. Amelioration of colitis in mice by Leuconostoc lactis EJ-1 by M1 to M2 macrophage polarization. Microbiol. Immunol. 64: 133-142. https://doi.org/10.1111/1348-0421.12752
  17. Fiorucci S, Mencarelli A, Palazzetti B, Sprague AG, Distrutti E, Morelli A, et al. 2002. Importance of innate immunity and collagen binding integrin alpha1beta1 in TNBS-induced colitis. Immunity 17: 769-780. https://doi.org/10.1016/S1074-7613(02)00476-4
  18. M F Neurath, I Fuss, M Pasparakis, L Alexopoulou, S Haralambous, K H Meyer zum Buschenfelde, W Strober, et al. 1997. Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice. Eur. J. Immunol. 27: 1743-1750. https://doi.org/10.1002/eji.1830270722
  19. Fiorucci S, Mencarelli A, Palazzetti B, Distrutti E, Vergnolle N, Hollenberg MD, et al. 2001. Proteinase-activated receptor (PAR)-2 is an anti-inflammatory signal for colonic lamina propria lymphocytes in a mouse model of colitis. Proc. Natl. Acad. Sci. USA 98: 13936-13941. https://doi.org/10.1073/pnas.241377298
  20. Ruder B, Atreya R, Becker C. 2019. Tumour necrosis factor alpha in intestinal homeostasis and gut related diseases. Int. J. Mol. Sci. 20: 1887.
  21. Min SW, Ryu SN, Kim DH. 2010. Anti-inflammatory effects of black rice, cyanidin-3-O-β-D-glycoside, and its metabolites, cyanidin and protocatechuic acid. Int. Immunopharmacol. 10: 959-966. https://doi.org/10.1016/j.intimp.2010.05.009
  22. Barens PJ, Karin M. 1997. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336: 1066-1071. https://doi.org/10.1056/NEJM199704103361506
  23. Collins T, Read MA, Neish AS, Whitley MZ, Thanos D, Maniatis T. 1995. Transcriptional regulation of endothelial cell adhesion molecules: NF-κB and cytokine inducible enhancers. FASEB. J. 9: 899-909. https://doi.org/10.1096/fasebj.9.10.7542214
  24. Lee SH. 2015. Intestinal permeability regulation by tight junction: implication on inflammatory bowel diseases. Intest. Res. 13: 11-18. https://doi.org/10.5217/ir.2015.13.1.11
  25. Adlerberth I, Ahrne S, Johansson ML, Molin G, Hanson LA, Wold AE. 1996. A mannose-specific adherence mechanism in Lactobacillus plantarum conferring binding to the human colonic cell line HT-29. Appl. Environ. Microbiol. 62: 2244-2251. https://doi.org/10.1128/aem.62.7.2244-2251.1996
  26. Laparra JM, Sanz Y. 2009. Comparison of in vitro models to study bacterial adhesion to the intestinal epithelium. Lett. Appl. Microbiol. 49: 695-701. https://doi.org/10.1111/j.1472-765X.2009.02729.x
  27. Arboleya S, Ruas-Madiedo P, Margolles A, Solis G, Salminen S, de Los Reyes-Gavilan CG, et al. 2011. Characterization and in vitro properties of potentially probiotic Bifidobacterium strains isolated from breast-milk. Int. J. Food Microbiol. 149: 28-36. https://doi.org/10.1016/j.ijfoodmicro.2010.10.036
  28. Sharma S, Kanwar SS. 2017. Adherence potential of indigenous lactic acid bacterial isolates obtained from fermented foods of Western Himalayas to intestinal epithelial Caco-2 and HT-29 cell lines. J. Food Sci. Technol. 54: 3504-3511. https://doi.org/10.1007/s13197-017-2807-1
  29. Fava F, Danese S. 2011. Intestinal microbiota in inflammatory bowel disease: friend of foe?. World J. Gastroenterol. 7: 557-666. https://doi.org/10.3748/wjg.v17.i5.557